Fiduciary Trust Co Buys 1,564 Shares of The Procter & Gamble Company (NYSE:PG)

Fiduciary Trust Co increased its stake in The Procter & Gamble Company (NYSE:PG) by 0.4% during the third quarter, Holdings Channel reports. The firm owned 367,831 shares of the company’s stock after acquiring an additional 1,564 shares during the period. Procter & Gamble makes up approximately 0.9% of Fiduciary Trust Co’s investment portfolio, making the stock its 20th biggest position. Fiduciary Trust Co’s holdings in Procter & Gamble were worth $63,708,000 at the end of the most recent reporting period.

A number of other hedge funds also recently modified their holdings of the stock. Concurrent Investment Advisors LLC grew its position in Procter & Gamble by 4.5% in the third quarter. Concurrent Investment Advisors LLC now owns 94,109 shares of the company’s stock valued at $16,300,000 after acquiring an additional 4,035 shares during the last quarter. Radnor Capital Management LLC bought a new stake in shares of Procter & Gamble during the third quarter worth about $5,705,000. Welch Group LLC grew its holdings in shares of Procter & Gamble by 0.9% during the third quarter. Welch Group LLC now owns 323,870 shares of the company’s stock worth $56,094,000 after purchasing an additional 2,990 shares during the last quarter. Swiss National Bank grew its holdings in shares of Procter & Gamble by 0.6% during the third quarter. Swiss National Bank now owns 7,005,790 shares of the company’s stock worth $1,213,403,000 after purchasing an additional 39,000 shares during the last quarter. Finally, GAMMA Investing LLC grew its holdings in shares of Procter & Gamble by 67.2% during the second quarter. GAMMA Investing LLC now owns 26,803 shares of the company’s stock worth $4,420,000 after purchasing an additional 10,777 shares during the last quarter. Institutional investors own 65.77% of the company’s stock.

Procter & Gamble Trading Up 0.0 %

Shares of Procter & Gamble stock opened at $179.34 on Thursday. The stock has a fifty day simple moving average of $170.22 and a 200 day simple moving average of $168.90. The Procter & Gamble Company has a 12-month low of $142.50 and a 12-month high of $180.43. The company has a market capitalization of $422.35 billion, a P/E ratio of 30.92, a price-to-earnings-growth ratio of 3.82 and a beta of 0.42. The company has a current ratio of 0.75, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50.

Procter & Gamble (NYSE:PG) last released its quarterly earnings results on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, topping the consensus estimate of $1.90 by $0.03. The business had revenue of $21.74 billion for the quarter, compared to analysts’ expectations of $21.99 billion. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The firm’s revenue for the quarter was down .6% compared to the same quarter last year. During the same period in the previous year, the company earned $1.83 earnings per share. On average, sell-side analysts anticipate that The Procter & Gamble Company will post 6.96 earnings per share for the current fiscal year.

Procter & Gamble Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were given a dividend of $1.0065 per share. This represents a $4.03 annualized dividend and a dividend yield of 2.24%. The ex-dividend date of this dividend was Friday, October 18th. Procter & Gamble’s dividend payout ratio is presently 69.48%.

Analyst Ratings Changes

Several analysts have recently weighed in on PG shares. Evercore ISI boosted their price target on Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a report on Monday, October 21st. Piper Sandler assumed coverage on Procter & Gamble in a report on Tuesday, September 24th. They set a “neutral” rating and a $174.00 price target on the stock. Barclays lowered Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price objective on the stock. in a research note on Monday, September 30th. Hsbc Global Res raised Procter & Gamble to a “strong-buy” rating in a research note on Friday, October 4th. Finally, Wolfe Research raised Procter & Gamble to a “strong-buy” rating in a research note on Friday, August 23rd. Eight analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $180.45.

Insider Transactions at Procter & Gamble

In other Procter & Gamble news, insider Balaji Purushothaman sold 12,800 shares of the business’s stock in a transaction dated Thursday, November 21st. The shares were sold at an average price of $172.73, for a total value of $2,210,944.00. Following the transaction, the insider now directly owns 11,595 shares in the company, valued at $2,002,804.35. The trade was a 52.47 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO R. Alexandra Keith sold 1,992 shares of the business’s stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $170.00, for a total transaction of $338,640.00. Following the completion of the transaction, the chief executive officer now owns 13,783 shares in the company, valued at approximately $2,343,110. The trade was a 12.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 35,233 shares of company stock worth $6,024,234 in the last ninety days. Company insiders own 0.18% of the company’s stock.

About Procter & Gamble

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.